Bills by Topic Results
Bills that have passed the Legislature are shown in bold text with an * preceding them.
DRUGS
   (See also HEALTH CARE; INSTITUTIONAL REVIEW BOARD, WASHINGTON STATE; MENTAL HEALTH; PHARMACIES AND PHARMACISTS; SENTENCES AND SENTENCING; SUBSTANCE USE DISORDER) |
|
|
Cannabinoid products, hemp-derived, sale as CBD/class B cannabinoid without indicated concentration/contents, prohibiting:
SB 5951 |
|
|
Cannabinoid products, limiting sellers of certain, compliance/enforcement grant program for local health departments:
SSB 5983 |
|
|
Cannabinoids, artificial/synthetically derived, medical marijuana products with, sales/use tax exemption exclusion of:
SHB 1668, 2SHB 1668, HB 2122, SB 5983 |
|
|
Cannabinoids, artificial/synthetically derived, prohibiting in medical marijuana products, when:
SHB 1668, 2SHB 1668 |
|
|
Cannabinoids, definitions for "plant Cannabis" and "tetrahydrocannabinol"/"THC":
SSB 5983 |
|
|
Cannabinoids, definitions for artificial and synthetically derived cannabinoids:
HB 1668, SHB 1668, SB 5547 |
|
|
Cannabinoids, definitions for artificial, naturally occurring, and impairing cannabinoids:
SB 5767 |
|
|
Cannabinoids, definitions for artificial, synthetically derived, and impairing cannabinoids:
2SHB 1668, HB 2122, SB 5983 |
|
|
Cannabinoids, definitions for artificial, synthetically derived, and impairing cannabinoids, scientific panel to review:
HB 2123, SB 5981 |
|
|
Cannabinoids, hemp-derived, processing and use by marijuana processor:
SB 5767 |
|
|
Cannabinoids, products with THC above 0.3%, limiting sellers of, compliance/enforcement grant program:
HB 2123, SB 5981 |
|
|
Cannabinoids, products with THC above 0.3%, sales only by licensed cannabis producers/processors/retailers, with exception:
SSB 5983 |
|
|
Cannabinoids, products with THC above 0.3%, sales only by licensed marijuana producers/processors/retailers:
HB 1668, SHB 1668, 2SHB 1668, HB 2122, HB 2123, SB 5547, SB 5981, SB 5983 |
|
|
Cannabinoids, scientific panel concerning, convening to review research/data/other jurisdictions' regulations:
HB 2123, SB 5981, SSB 5983 |
|
|
Cannabinoids, that may be impairing, enforcement operations regarding:
SB 5983 |
|
|
Cannabinoids, that may be impairing, enforcement operations regarding, fee surcharge for certain licensees to fund:
HB 2122 |
|
|
Cannabinoids, that may be impairing, regulation of and definitions and requirements for:
HB 1668, SHB 1668, 2SHB 1668, HB 2122, SB 5547, SB 5983 |
|
|
Cannabinoids, that may be impairing, to be sold only by licensed marijuana producers, processors, and retailers:
HB 1668, SHB 1668, 2SHB 1668, HB 2122, SB 5547, SB 5983 |
|
|
Cannabis industry, social equity in, grant program/mentors roster/legislative task force/social equity license applicants:
*
ESHB 1443, CH 169 (2021) |
|
|
Cannabis industry, social equity in, grant/pilot program/legislative task force/social equity license applicants:
HB 1443, SB 5388 |
|
|
Cannabis laboratory quality standards, interagency coordination team for, creating:
*
HB 1859, CH 135 (2022), SB 5699, SSB 5699 |
|
|
Cannabis product use prevention/cessation, funding via dedicated cannabis account appropriations:
SSB 5796,
*
E2SSB 5796, CH 169 (2022) |
|
|
Cannabis social equity technical assistance grant program, funds from dedicated cannabis account for:
SB 5796, SSB 5796,
*
E2SSB 5796, CH 169 (2022) |
|
|
Cannabis, business/nonprofit entity applicants for licenses, ownership interest holders/additional application fee:
HB 1667 |
|
|
Cannabis, cannabis equity grant program, establishing with certain funds:
HB 1827, SB 5706 |
|
|
Cannabis, cannabis equity grant program, establishing with funds from community reinvestment account:
SB 5796 |
|
|
Cannabis, cannabis policy, task force on, establishing:
HB 1260 |
|
|
Cannabis, concentrates with high THC concentrations, regulation of:
HB 1463 |
|
|
Cannabis, craft cannabis endorsement for licensed marijuana producers and processors:
HB 1855 |
|
|
Cannabis, craft cannabis producer/processor license, creating:
HB 1260 |
|
|
Cannabis, dedicated cannabis account, appropriations for cannabis- and health-related matters:
*
E2SSB 5796, CH 169 (2022) |
|
|
Cannabis, dedicated cannabis account, appropriations for marijuana- and health-related matters:
SB 5796, SSB 5796 |
|
|
Cannabis, dedicated cannabis account, appropriations for tobacco/substance use and drug enforcement:
SB 5796, SSB 5796,
*
E2SSB 5796, CH 169 (2022) |
|
|
Cannabis, dedicated cannabis account, deposits into community reinvestment account from, uses of:
SB 5796, SSB 5796 |
|
|
Cannabis, dedicated cannabis account, renaming dedicated marijuana account as, appropriations from:
SB 5796, SSB 5796,
*
E2SSB 5796, CH 169 (2022) |
|
|
Cannabis, employee screening test indicating, terminating or not hiring person due to, prohibiting:
SB 5517 |
|
|
Cannabis, licensed producers/processors/retailers, limiting sales of cannabinoid products with THC above 0.3% to, with exception:
SSB 5983 |
|
|
Cannabis, licenses, cannabis social equity grant, low-interest loan, and technical assistance program:
HB 2022, SHB 2022 |
|
|
Cannabis, licenses, marijuana producers/processors, social equity license applicants to include, when:
HB 2022, SHB 2022 |
|
|
Cannabis, licenses, social equity program, grants/loans/roster of mentors for technical assistance, funding for:
HB 2022, SHB 2022 |
|
|
Cannabis, licenses, social equity program, license mobility and lifting of distance restrictions, when:
HB 2022 |
|
|
Cannabis, marijuana testing laboratory quality standards, establishing and maintaining:
SB 5699, SSB 5699 |
|
|
Cannabis, medical use, various provisions:
HB 1105, HB 1463, SHB 1668, 2SHB 1668, SB 5004, ESSB 5004 |
|
|
Cannabis, replacing "marijuana" with "cannabis" throughout Revised Code of Washington:
HB 1210, SHB 1210,
*
2SHB 1210, CH 16 (2022) |
|
|
Cannabis, retail licenses, social equity license applicants, modifying provisions:
HB 2022, SHB 2022 |
|
|
Cannabis, retail outlets, attempt or incident of robbery in first or second degree at, reporting requirements:
HB 2029, SB 5927 |
|
|
Cannabis, testing laboratory quality standards, establishing and maintaining:
*
HB 1859, CH 135 (2022) |
|
|
Cannabis, Washington state cannabis commission, establishing:
SB 5365 |
|
|
Cannabis, Washington state cannabis commission, establishment and role of:
HB 1710 |
|
|
Cannabis, Washington state cannabis cultivation commission, establishment and role of:
SHB 1710 |
|
|
Cannabis, wholesale sales of marijuana/marijuana products, persons making, B&O tax rate and surcharge for:
SB 5365 |
|
|
CBD product, sale of hemp product with less than one-third of indicated CBD amount as, prohibiting:
SSB 5951 |
|
|
Clinical trials, demographic diversity program for, establishing:
SB 5723, SSB 5723 |
|
|
Controlled and counterfeit substances possession, laws and ordinances enactment by municipalities, authority for:
HB 1562 |
|
|
Controlled substance homicide offenses, offender release/escape/etc., victim notification:
SB 5245,
*
ESSB 5245, CH 82 (2022) |
|
|
Controlled substance, juvenile consuming, delivery from law enforcement custody to evaluation/treatment facility:
HB 1559 |
|
|
Controlled substances act, civil asset forfeiture under, certain amounts to be remitted to state for deposit:
SB 5728,
*
SSB 5728, CH 162 (2022) |
|
|
Controlled substances act, civil asset forfeiture under, seizing agency recordkeeping/reporting/burden of proof:
SB 5733, SSB 5733, 2SSB 5733 |
|
|
Controlled substances act, convictions under, excluding from offender score, when:
SB 5035, SSB 5035 |
|
|
Controlled substances act, convictions under, resentencing hearing for offender, when:
SB 5361,
*
SSB 5361, CH 286 (2021) |
|
|
Controlled substances, imitation, convictions for crimes involving, resentencing hearing for offender, when:
SB 5361,
*
SSB 5361, CH 286 (2021) |
|
|
Controlled substances, naturopathic physician prescriptive authority, expanding:
SB 5088 |
|
|
Controlled substances, possession of, legislative work group on, establishing:
SB 5475 |
|
|
Controlled substances, uniform act, dedicated cannabis account funds for administration of:
SB 5796, SSB 5796,
*
E2SSB 5796, CH 169 (2022) |
|
|
Correctional facilities, body scanner pilot program, drug free prisons act for:
SB 5695, SSB 5695,
*
2SSB 5695, CH 160 (2022) |
|
|
COVID-19, health care provider use of "known" drug/biological product/mineral/vitamin remedies to prevent/treat/cure:
HB 2065 |
|
|
Drugs or vaccines, in limited supply, health care entity providing to donors or board members, prohibiting:
SB 5418 |
|
|
Fentanyl, controlled substances homicide when recklessly containing, class A felony:
SB 5524 |
|
|
Fentanyl, equipment for testing for, exempting from "drug paraphernalia" prohibitions:
SB 5509 |
|
|
Fentanyl, knowingly possessing without prescription, criminal penalties for:
HB 1922, HB 1937 |
|
|
Fentanyl, public outreach campaign concerning dangers of, developing:
HB 1937 |
|
|
HIV antiviral drugs, medicaid coverage when FDA-approved:
HB 2079, SB 5551 |
|
|
Infants, drug-exposed, pediatric transitional care services for, parent-child interaction during:
HB 1903 |
|
|
Injection sites, supervised, city/county prohibitions as condition for imposing certain local sales/use taxes:
HB 1526, HB 1541 |
|
|
Injection sites, supervised, county prohibition as condition for receiving document recording surcharge funds:
SB 5954 |
|
|
Insulin, maximum insurance coverage enrollee payment for 30-day supply, reducing:
SB 5546 |
|
|
Insulin, maximum insurance enrollee payment for 30-day supply, reducing:
*
SSB 5546, CH 10 (2022) |
|
|
Insulin, once-yearly emergency 30-day supply of, strategies for providing:
*
SHB 1728, CH 205 (2022), SB 5546 |
|
|
Insulin, purchase and distribution of, health care authority partnerships for:
*
ESSB 5203, CH 274 (2021) |
|
|
Insulin, total cost of insulin work group, expanding duties and extending expiration of:
SB 5546 |
|
|
Insulin, total cost of insulin work group, extending deadlines/expiration of:
HB 1728,
*
SHB 1728, CH 205 (2022) |
|
|
Kratom, mitragynine and 7-hydroxymitragynine, as controlled substances, designating:
SB 5743 |
|
|
Kratom, processor prohibitions, Washington kratom consumer protection act:
SB 5941 |
|
|
Legend drug act, exemption, dialysate/dialysis device manufacturers dispensing directly to patients:
HB 1675,
*
SHB 1675, CH 23 (2022), SB 5507 |
|
|
Marijuana products, adding hemp-derived cannabinoids to, marijuana processor authority for:
SB 5767 |
|
|
Marijuana, business/nonprofit entity applicants for licenses, ownership interest holders/additional application fee:
HB 1667 |
|
|
Marijuana, businesses, license issuance for, prohibiting due to written objection based on zoning ordinances:
HB 1414 |
|
|
Marijuana, cannabis policy, task force on, establishing:
HB 1260 |
|
|
Marijuana, cannabis retail outlets, attempt or incident of robbery in first or second degree at, reporting requirements:
HB 2029, SB 5927 |
|
|
Marijuana, concentrates with high THC concentrations, regulation of:
HB 1463 |
|
|
Marijuana, craft cannabis producer/processor license, creating:
HB 1260 |
|
|
Marijuana, dedicated cannabis account, appropriations for cannabis- and health-related matters:
*
E2SSB 5796, CH 169 (2022) |
|
|
Marijuana, dedicated cannabis account, appropriations for marijuana- and health-related matters:
SB 5796, SSB 5796 |
|
|
Marijuana, dedicated cannabis account, appropriations for tobacco/substance use and drug enforcement:
SB 5796, SSB 5796,
*
E2SSB 5796, CH 169 (2022) |
|
|
Marijuana, dedicated cannabis account, deposits into community reinvestment account from, uses of:
SB 5796, SSB 5796 |
|
|
Marijuana, dedicated cannabis account, renaming dedicated marijuana account as, appropriations from:
SB 5796, SSB 5796,
*
E2SSB 5796, CH 169 (2022) |
|
|
Marijuana, employee screening test indicating, terminating or not hiring person due to, prohibiting:
SB 5517 |
|
|
Marijuana, excluding hemp from definition of, when:
HB 1668, SHB 1668, 2SHB 1668, SB 5547 |
|
|
Marijuana, licensed processors, hemp-derived cannabinoids processing/using and adding to marijuana products by:
SB 5767 |
|
|
Marijuana, licensed producers and processors, craft cannabis endorsement for, requirements:
HB 1855 |
|
|
Marijuana, licensed producers and processors, excise tax on, smaller local government authority to impose:
HB 1933 |
|
|
Marijuana, licensed producers/processors/retailers, limiting sales of cannabinoids that may be impairing to sales by:
HB 1668, SHB 1668, 2SHB 1668, HB 2122, SB 5547, SB 5983 |
|
|
Marijuana, licenses, cannabis social equity grant, low-interest loan, and technical assistance program:
HB 2022, SHB 2022 |
|
|
Marijuana, licenses, producers and processors, social equity license applicants to include, when:
HB 2022, SHB 2022 |
|
|
Marijuana, licenses, social equity in cannabis, legislative task force on, adding members/purposes/duties:
HB 1443,
*
ESHB 1443, CH 169 (2021), SB 5388 |
|
|
Marijuana, licenses, social equity in marijuana, legislative task force on, replacing "marijuana" with "cannabis":
HB 1443,
*
ESHB 1443, CH 169 (2021), SB 5388 |
|
|
Marijuana, medical use, arrest protections for qualifying patients and designated providers:
HB 1105 |
|
|
Marijuana, medical use, concentrates with high THC concentration, requirements/prohibitions/age restriction:
HB 1463 |
|
|
Marijuana, medical use, excise tax exemption for sales, when:
SB 5004, ESSB 5004 |
|
|
Marijuana, medical use, products containing artificial/synthetically derived cannabinoids, prohibiting, when:
SHB 1668, 2SHB 1668 |
|
|
Marijuana, medical use, sales/use tax exemption, excluding products with artificial/synthetically derived cannabinoids from:
SHB 1668, 2SHB 1668, HB 2122, SB 5983 |
|
|
Marijuana, replacing "marijuana" with "cannabis" throughout Revised Code of Washington:
HB 1210, SHB 1210,
*
2SHB 1210, CH 16 (2022) |
|
|
Marijuana, residential production, processing, or possession:
HB 1019, SHB 1019 |
|
|
Marijuana, retail licenses, cannabis social equity assistance grant program, pilot program related to, creating:
HB 1443, SB 5388 |
|
|
Marijuana, retail licenses, cannabis social equity license applicants, modifying provisions:
HB 2022, SHB 2022 |
|
|
Marijuana, retail licenses, cannabis social equity technical assistance competitive grant program, modifications:
HB 1443,
*
ESHB 1443, CH 169 (2021), SB 5388 |
|
|
Marijuana, retail licenses, social equity license applicants, modifying provisions:
HB 1443,
*
ESHB 1443, CH 169 (2021), SB 5388 |
|
|
Marijuana, testing laboratory quality standards, establishing and maintaining:
SB 5699, SSB 5699 |
|
|
Marijuana, testing requirements for, producers/processors/certified labs/certified lab employees compliance with:
SB 5767 |
|
|
Marijuana, Washington state cannabis commission, establishing:
SB 5365 |
|
|
Marijuana, Washington state cannabis commission, establishment and role of:
HB 1710 |
|
|
Marijuana, Washington state cannabis cultivation commission, establishment and role of:
SHB 1710 |
|
|
Marijuana/marijuana products, wholesale sales of, persons making, B&O tax rate and surcharge for:
SB 5365 |
|
|
Marketing/advertising to minors via internet/mobile application, prohibitions:
HB 1697, SHB 1697 |
|
|
Naloxone, opioid overdose reversal medication bulk purchasing and distribution program, establishing:
*
2SSB 5195, CH 273 (2021) |
|
|
Naloxone, opioid overdose reversal medication dispensing/distributing or prescribing in hospital/in connection with treatment:
*
2SSB 5195, CH 273 (2021) |
|
|
Naloxone, opioid overdose reversal medication dispensing/prescribing in hospital/in connection with treatment:
SSB 5195 |
|
|
Naloxone, opioid overdose reversal medication prescription in emergency department or involuntary treatment:
SB 5195 |
|
|
Offenses, consuming or opening package containing controlled or counterfeit substance in public, civil infraction:
HB 1578 |
|
|
Offenses, controlled substance distribution to person under 18, mandatory confinement of at least 7 years:
HB 1561 |
|
|
Offenses, controlled substance, knowingly possessing, class C felony with diversion option, when:
SB 5954 |
|
|
Offenses, controlled substance, sentencing enhancement for certain, eliminating:
HB 1169, ESHB 1169 |
|
|
Offenses, controlled substance, unlawfully possessing, class C felony, when:
SB 5523 |
|
|
Offenses, controlled substance, unlawfully possessing, restricting to knowingly possessing, when:
SB 5468, SB 5475 |
|
|
Offenses, controlled substance/counterfeit, manufacture/sale/distribution/etc., offenses/penalties, expanding:
HB 1561 |
|
|
Offenses, controlled substance/counterfeit/legend drug, knowingly possessing more than personal use amount:
HB 1578 |
|
|
Offenses, controlled substance/counterfeit/legend drug, unknowingly possessing, civil infraction and fine:
SB 5471 |
|
|
Offenses, controlled substance/counterfeit/legend drug, unlawfully possessing, restricting to knowingly possessing, when:
HB 1560, HB 1578, SB 5471 |
|
|
Offenses, controlled substance/counterfeit/legend drug/marijuana, statewide drug diversion database, developing:
HB 1892 |
|
|
Offenses, controlled substance/counterfeit/legend drug/marijuana, unlawfully possessing, optional referral for services:
SB 5954 |
|
|
Offenses, controlled substance/counterfeit/legend drug/marijuana, unlawfully possessing, restricting to knowingly possessing, when:
*
ESB 5476, CH 311 (2021) PV |
|
|
Offenses, controlled substance/counterfeit/legend drug/marijuana, unlawfully possessing, SUD intervention, when:
SB 5976 |
|
|
Offenses, controlled substances homicide, when recklessly containing fentanyl, class A felony:
SB 5524 |
|
|
Offenses, controlled substances, endangerment with, to include any controlled substance:
HB 1561 |
|
|
Offenses, controlled substances/counterfeits/legend drugs personal use possession, criminal penalties, eliminating:
HB 1499, SHB 1499, HB 1578 |
|
|
Offenses, controlled/counterfeit substances possession, laws/ordinances enactment by municipalities, authority for:
HB 1562 |
|
|
Offenses, counterfeit substance, knowingly possessing, class C felony with diversion option, when:
SB 5954 |
|
|
Offenses, counterfeit substance, knowingly possessing, class C felony, when:
SB 5523 |
|
|
Offenses, criminal, excluding from offender score, when:
SB 5035, SSB 5035 |
|
|
Offenses, drug paraphernalia use, prohibitions, modifying:
HB 1578,
*
ESB 5476, CH 311 (2021) PV |
|
|
Offenses, drug paraphernalia, prohibitions, exempting fentanyl testing equipment from:
SB 5509 |
|
|
Offenses, fentanyl, knowingly possessing without prescription, criminal penalties for:
HB 1922, HB 1937 |
|
|
Offenses, level I, offender score sentencing grid for, modification of:
HB 1307 |
|
|
Offenses, special drug offender sentencing alternative for driving under the influence:
SB 5573, SSB 5573 |
|
|
Offenses, special drug offender sentencing alternative for impaired driving offenses:
ESB 5054 |
|
|
Offenses, State v. Blake reimbursement account, creating:
HB 1578 |
|
|
Offenses, State v. Blake, resentencing hearings and hearings to vacate convictions related to, conducting:
HB 1578,
*
ESB 5476, CH 311 (2021) PV |
|
|
Offenses, State v. Blake, simple drug possession convictions, vacating, and establishing refund bureau:
SB 5663, SSB 5663 |
|
|
Offenses, State v. Blake, simple drug possession convictions, vacating, and legal financial obligations refunding:
2SSB 5663 |
|
|
Opioid overdose reversal medication bulk purchasing and distribution program, establishing:
*
2SSB 5195, CH 273 (2021) |
|
|
Opioid overdose reversal medication, dispensing of or prescription for, when:
SSB 5195 |
|
|
Opioid overdose reversal medication, dispensing or distribution of or prescription for, when:
*
2SSB 5195, CH 273 (2021) |
|
|
Opioid overdose reversal medication, dispensing/distribution by nurse in hospital ER, requirements:
*
HB 1761, CH 25 (2022) |
|
|
Opioid overdose reversal medication, prescription in emergency department or involuntary treatment:
SB 5195 |
|
|
Over-the-counter drugs, shop local and save sales and use tax holiday to include:
HB 2018 |
|
|
Personal use amount, definition and possession of, provisions:
HB 1499, SHB 1499, HB 1578 |
|
|
Personal use amounts, legend drugs and controlled and counterfeit substances, reviewing, when:
HB 1578 |
|
|
Prescription drug affordability board, establishing:
HB 1671, SB 5532, SSB 5532,
*
2SSB 5532, CH 153 (2022) |
|
|
Prescription drug and OTC medication information, on school district/educational service district websites:
HB 1759, SHB 1759 |
|
|
Prescription, compounding of drugs, revising definition to exclude reconstitution and mixing:
HB 1445,
*
SHB 1445, CH 78 (2021) |
|
|
Prescription, cost-sharing amounts to be counted against out-of-pocket maximum, deductible, etc.:
HB 1713, SB 5610,
*
SSB 5610, CH 228 (2022) |
|
|
Prescription, defined cost-sharing for, to be based on price reduced by rebates/discounts accruing to carrier:
SB 5888 |
|
|
Prescription, for mental health conditions, continuity of coverage of, requirements/prohibitions, when:
SB 5794, ESSB 5794 |
|
|
Prescription, generic, production/distribution/purchase of, health care authority partnerships for:
SB 5203,
*
ESSB 5203, CH 274 (2021) |
|
|
Prescription, label/container for, language requirements for directions for use/side effects on:
HB 1852, SB 5840 |
|
|
Prescription, label/container/information for, language requirements for directions for use/side effects on/in:
ESHB 1852 |
|
|
Prescription, mail order services, unintentional use/enrollment:
SB 5076 |
|
|
Prescription, prescribing psychologists, certification to exercise prescriptive authority as:
HB 1863 |
|
|
Prescription, take-back program, modifying provisions:
HB 1161, SHB 1161,
*
2SHB 1161, CH 155 (2021) |
|
|
Prescription, unsupported price increases, protections from:
SB 5020, SSB 5020 |
|
|
Prescription, warehousing/reselling, preferential B&O tax rate, eliminating to provide SUD recovery funding:
HB 2091, SB 5952 |
|
|
Regulating cannabis/tobacco/alcohol/vapor products, behavioral health prevention/equity impact framework for:
HB 2035 |